Literature DB >> 11264666

Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum.

Y Sekine-Aizawa1, E Hama, K Watanabe, S Tsubuki, M Kanai-Azuma, Y Kanai, H Arai, H Aizawa, N Iwata, T C Saido.   

Abstract

The matrix metalloproteinase (MMP) family, comprising more than 20 isoforms, modulates the extracellular milieu by degrading extracellular matrix (ECM) proteins. Because MMP is one of the few groups of proteinases capable of hydrolysing insoluble fibrillar proteins, they are likely to play crucial roles in regulating both normal and pathophysiological processes in the brain. However, little is yet known about their possible neuronal functions due presumably to their unusual redundancy and to the absence of a complete catalogue of isoforms. As an initial step in understanding the MMP system in the brain, we analysed an expression spectrum of MMP in rat brain using RT-PCR and discovered a novel brain-specific MMP, MT5-MMP. MT5-MMP was the predominant species among the nongelatinase-type isoforms in brain. MT5-MMP, present in all brain tissues examined, was most strongly expressed in cerebellum and was localized in the membranous structures of expressing neurons, as assessed biochemically and immunohistochemically. In cerebellum, its expression was regulated developmentally and was closely associated with dendritic tree formation of Purkinje cells, suggesting that MT5-MMP may contribute to neuronal development. Furthermore, its stable postdevelopmental expression and colocalization with senile plaques in Alzheimer brain indicates possible roles in neuronal remodeling naturally occurring in adulthood and in regulating pathophysiological processes associated with advanced age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264666     DOI: 10.1046/j.0953-816x.2001.01462.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  27 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 2.  Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Authors:  Leszek Kaczmarek; Joanna Lapinska-Dzwonek; Sylwia Szymczak
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  MT5-MMP regulates adult neural stem cell functional quiescence through the cleavage of N-cadherin.

Authors:  Eva Porlan; Beatriz Martí-Prado; José Manuel Morante-Redolat; Antonella Consiglio; Ana C Delgado; Robert Kypta; Carlos López-Otín; Martina Kirstein; Isabel Fariñas
Journal:  Nat Cell Biol       Date:  2014-06-22       Impact factor: 28.824

Review 4.  Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Santiago Rivera; Laura García-González; Michel Khrestchatisky; Kévin Baranger
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

5.  Long-term expression of tissue-inhibitor of matrix metalloproteinase-1 in the murine central nervous system does not alter the morphological and behavioral phenotype but alleviates the course of experimental allergic encephalomyelitis.

Authors:  Gioia E M Althoff; David P Wolfer; Nina Timmesfeld; Benoit Kanzler; Heinrich Schrewe; Axel Pagenstecher
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

Review 6.  Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

Authors:  George W Huntley
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

7.  Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins.

Authors:  Sara Monea; Bryen A Jordan; Sapna Srivastava; Sunita DeSouza; Edward B Ziff
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

Review 8.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

9.  Subcellular localization of intercellular adhesion molecule-5 (telencephalin) in the visual cortex is not developmentally regulated in the absence of matrix metalloproteinase-9.

Authors:  Emily A Kelly; Marie-Eve Tremblay; Carl G Gahmberg; Li Tian; Ania K Majewska
Journal:  J Comp Neurol       Date:  2014-02-15       Impact factor: 3.215

Review 10.  Trafficking in Alzheimer's Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin.

Authors:  Simone Eggert; Carolin Thomas; Stefan Kins; Guido Hermey
Journal:  Mol Neurobiol       Date:  2017-10-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.